BETAMETHASONE DIPROPIONATE gel USA - engelsk - NLM (National Library of Medicine)

betamethasone dipropionate gel

physicians total care, inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone dipropionate - unii:826y60901u) - betamethasone dipropionate 0.64 mg in 1 g - betamethasone dipropionate gel (augmented) is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. treatment beyond two consecutive weeks is not recommended, and the total dose should not exceed 50 g per week because of potential for the drug to suppress the hypothalamic-pituitary-adrenal (hpa) axis. this product is not recommended for use in pediatric patients under 12 years of age. betamethasone dipropionate gel (augmented) is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

BETAMETHASONE VALERATE cream USA - engelsk - NLM (National Library of Medicine)

betamethasone valerate cream

rebel distributors corp. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1 mg in 1 g - betamethasone valerate cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. betamethasone valerate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Betafuse 1 mg/g + 5 mg/g gel for dogs Irland - engelsk - HPRA (Health Products Regulatory Authority)

betafuse 1 mg/g + 5 mg/g gel for dogs

norbrook laboratories (ireland) limited - betamethasone valerate; fusidic acid hemihydrate - gel - 1, 5 milligram(s)/gram - betamethasone and antibiotics

Fuselieve 1 mg/g + 5 mg/g Gel for Dogs Irland - engelsk - HPRA (Health Products Regulatory Authority)

fuselieve 1 mg/g + 5 mg/g gel for dogs

norbrook laboratories (ireland) limited - betamethasone valerate; fusidic acid hemihydrate - gel - 1,5 milligram(s)/gram - betamethasone and antibiotics

Betnovate Scalp Application 0.1% w/w Cutaneous Solution Malta - engelsk - Medicines Authority

betnovate scalp application 0.1% w/w cutaneous solution

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - betamethasone valerate - cutaneous solution - betamethasone valerate 0.1 % (w/w) - corticosteroids, dermatological preparations

BETAMETHASONE DIPROPIONATE ointment USA - engelsk - NLM (National Library of Medicine)

betamethasone dipropionate ointment

prasco laboratories - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - augmented betamethasone dipropionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. augmented betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on augmented betamethasone dipropionate ointment use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that augmented betamethasone dipropionate ointment may increase the risk of having a low birthweight infant and to use augmented betamethasone dipropionate ointment on the smallest

GENTAVED TOPICAL- gentamicin sulfate and betamethasone valerate spray USA - engelsk - NLM (National Library of Medicine)

gentaved topical- gentamicin sulfate and betamethasone valerate spray

vedco, inc. - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications: for the treatment of infected superficial lesions in dogs caused by bacteria susceptible to gentamicin. contraindications: if hypersensitivity of any of the components occurs, discontinue treatment and institute appropriate therapy.

BETAGEN- gentamicin sulfate with betamethasone valerate spray USA - engelsk - NLM (National Library of Medicine)

betagen- gentamicin sulfate with betamethasone valerate spray

clipper distributing company llc - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

GENTAVED- gentamicin sulfate with betamethasone valerate spray USA - engelsk - NLM (National Library of Medicine)

gentaved- gentamicin sulfate with betamethasone valerate spray

vedco - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

GENONE- gentamicin sulfate with betamethasone valerate spray USA - engelsk - NLM (National Library of Medicine)

genone- gentamicin sulfate with betamethasone valerate spray

mwi - gentamicin sulfate (unii: 8x7386qrlv) (gentamicin - unii:t6z9v48ikg), betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - gentamicin 0.57 mg in 1 ml - indications : for the treatment of infected superficial lesions in dogs caused by bacteria sensitive to gentamicin. contraindications : if hypersensitivity of any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.